Articles From: Allergan files rebuttal to Valeant earnings to Danone Committed to All Business Units -- Update


By Russ Britt, MarketWatch LOS ANGELES (MarketWatch) -- While Valeant says that it handily beat analyst estimates for the third quarter, its current acquisition target, Botox maker Allergan Inc., offered its own take on the results.
Sign-up for Allergan files rebuttal to Valeant earnings investment picks
By Russ Britt, MarketWatch (Editor's note: Updated to show Chimerix drug used on Ebola patient.) LOS ANGELES (MarketWatch) -- The number of companies with a hand in trying to find an effective combatant against the deadly Ebola virus is growing almost as quickly as the disease spreads, and one player's drug was used to treat the Texas man stricken with the malady shortly after receiving regulatory approval on Monday The U.S. Food and Drug Administration has authorized a drug developed by Chimerix Inc. (CMRX) for use as an emergency investigational new treatment in the rapid deployment against Ebola.
Sign-up for UPDATE: Number of companies fighting Ebola grows, one wins fed OK investment picks
By Russ Britt, MarketWatch The salvoes that are being fired by Valeant Pharmaceuticals Inc. and Allergan Inc. in their takeover battle have come fast and furious, but one of the shots this week took an unexpected turn.
Sign-up for UPDATE: Allergan keeps a few secrets, court filing shows investment picks
By Russ Britt, MarketWatch LOS ANGELES (MarketWatch) -- Viacom Inc. is set to report fourth-quarter earnings on Thursday with high expectations from two key box-office successes during Hollywood's summer season.
Sign-up for What to look for in Viacom earnings investment picks
By Russ Britt, MarketWatch LOS ANGELES (MarketWatch) -- Walt Disney Co.'s shares have been moving like a freight train of late as have its earnings, and it seems this mouse will continue to roar.
Sign-up for UPDATE: What to look for in Disney earnings investment picks
By Russ Britt, MarketWatch LOS ANGELES (MarketWatch) -- When Time Warner Cable Inc. reports third-quarter earnings on Thursday, the answer some will be awaiting -- besides when and if it will be swallowed up by Comcast Corp.
Sign-up for What to look for in Time Warner Cable earnings investment picks
By Russ Britt, MarketWatch An expected drop in advertising revenue, coupled with increased expenses needed to bring Thursday night football games to broadcast television, could well leave investors disappointed when CBS Corp.
Sign-up for What to look for in CBS earnings investment picks
By Russ Britt, MarketWatch LOS ANGELES (MarketWatch) -- Walt Disney Co.'s shares have been moving like a freight train of late as have its earnings, and it seems this mouse will continue to roar.
Sign-up for What to look for in Disney earnings investment picks
By Russ Britt, MarketWatch LOS ANGELES (MarketWatch) -- Investors who saw a spinoff of consumer-products giant Kimberly-Clark Corp.
Sign-up for Ebola play Halyard Health stock gains are modest investment picks
By Russ Britt, MarketWatch LOS ANGELES (MarketWatch)-- Two earnings reports, coupled with a dose of internal drama, sent the shares of two drug makers tumbling Friday, with Salix Pharmaceuticals Ltd.
Sign-up for Drug companies Salix, Intercept reeling after earnings, drama investment picks
By Russ Britt, MarketWatch Media company had a good summer, but fall brought trouble LOS ANGELES (MarketWatch) -- Viacom Inc. is set to report fiscal fourth-quarter earnings on Thursday, ahead of the open, with high expectations from two key box-office successes during Hollywood's summer season.
Sign-up for UPDATE: What to look for in Viacom earnings investment picks
By Russ Britt, MarketWatch Media company had a good summer, but fall brought trouble LOS ANGELES (MarketWatch) -- Viacom Inc. is set to report fiscal fourth-quarter earnings on Thursday, ahead of the open, with high expectations from two key box-office successes during Hollywood's summer season.
Sign-up for UPDATE: What to look for in Viacom earnings investment picks
By Russ Britt, MarketWatch Actavis shares jump 5.5% while Allergan rises 1.4% LOS ANGELES (MarketWatch) -- This has got to be a new one in the merger game: the buyer's shares have gone up more than the company it's buying.
Sign-up for Actavis shares outpace buyout target's gains investment picks
By Russ Britt, MarketWatch Stock jumps as new treatment leaps past a testing step LOS ANGELES (MarketWatch) -- Plans by Biogen Idec Inc. to move directly from Phase I to Phase III testing on an Alzheimer's treatment boosted shares of the company nearly 7% early Tuesday.
Sign-up for UPDATE: Biogen Alzheimer's drug skips to Phase 3 testing investment picks
By Russ Britt, MarketWatch Fox Searchlight gets most movie nods; HBO leads in TV LOS ANGELES (MarketWatch) -- "Birdman," the feature film about a washed-up actor who tries to reclaim past glory by directing a Broadway play, and "Fargo," the miniseries reconstituting the disturbing 1996 film that garnered its own awards, led all prospects in Golden Globe nominations on Thursday.
Sign-up for 'Birdman,' 'Fargo' lead Golden Globe nominations investment picks
2014/11/17
By Russell Gold And Angela Chen Shares of Halliburton Co.
Sign-up for Halliburton to Buy Baker Hughes for $34.6 Billion -- 7th Update investment picks
2014/11/17
By Russell Gold And Angela Chen Shares of Halliburton Co.
Sign-up for Halliburton to Buy Baker Hughes for $34.6 Billion -- 6th Update investment picks
2014/11/20
By Ruth Bender, Eyk Henning and Shayndi RaiceFresenius, Permira make joint bid German health-care group Fresenius SE & Co.
Sign-up for Danone gets bid for medical-nutrition business investment picks
2014/11/19
By Ruth Bender, Eyk Henning and Shayndi Raice German health care group Fresenius SE & Co.
Sign-up for Fresenius, Permira Make Joint Bid For Danone Medical Unit - Update investment picks
2014/11/19
By Ruth Bender, Eyk Henning and Shayndi Raice German health care group Fresenius SE & Co.
Sign-up for Fresenius, Permira Make Joint Bid For Danone Medical Unit - Sources investment picks
2014/11/30
By Ruth Bender and Shayndi Raice PARIS--Deal-hungry Altice SA Sunday said it has entered exclusive talks to buy Portugal's former telecom monopoly from its Brazilian owner for EUR7.4 billion, as the Luxembourg telecom group nears its second-largest deal since buying French mobile company SFR.
Sign-up for Altice SA in Exclusive Talks With Oi SA to Buy PT Portugal -- Update investment picks
2014/11/21
By Ruth Bender BARCELONA --
Sign-up for Altice signals interest in buying Bouygues investment picks
2014/11/20
By Ruth Bender BARCELONA-- Orange SA is open to letting an outsider take control of Dailymotion as the French telecom operator revives its quest to expand the video streaming website.
Sign-up for Orange CEO Open to Selling Controlling Stake in Dailymotion investment picks
By Ruth Bender BARCELONA--Omnicom Group Inc. (OMC) Chief Executive John Wren no longer believes in the idea of merger of equals following the collapse earlier this year of the U.S. advertising giant's plans to merge with French rival Publicis Groupe SA (PUB.FR). "In my thoughts, the concept of merger of equals has gone away forever," Mr.
Sign-up for Omnicom CEO No Longer Believes in 'Merger of Equals' Concept investment picks
2014/11/21
By Ruth Bender BARCELONA--Talk of mergers among telecom firms in France has been so intense that executives are openly joking about it.
Sign-up for Merger Talk Among European Telecoms Reaches Fever Pitch investment picks
2014/11/20
By Ruth Bender BARCELONA--Telecom holding group Altice SA would be interested in buying Bouygues Telecom if the parent company decided it wanted to sell, chief executive Dexter Goei said Thursday, reviving the long-swirling topic of who might buy whom in the French telecommunications market.
Sign-up for Altice Would be Interested in Buying Bouygues Telecom -- CEO investment picks
2014/11/19
By Ruth Bender BARCELONA--WPP PLC Chief Executive Martin Sorrell said on Wednesday he would like to see the group's dividend payout ratio increase to 50% eventually, from its target of 45% for this year.
Sign-up for WPP Wants Dividend Payout Ratio to Increase to 50%, CEO Says investment picks
2014/12/12
By Ruth Bender PARIS--
Sign-up for Danone Committed to All Business Units investment picks
2014/12/12
By Ruth Bender PARIS--
Sign-up for Danone Committed to All Business Units -- 2nd Update investment picks
2014/12/12
By Ruth Bender PARIS--
Sign-up for Danone Committed to All Business Units -- Update investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Allergan files rebuttal to Valeant earnings to Danone Committed to All Business Units -- Update
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent